TrialFind
Saved trials
Back to results
Terminated
Phase 3
2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)
NCT02916056
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Phoenix, Arizona, United States
+70 additional locations
View on ClinicalTrials.gov
Official details
2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension) — TrialFind